SPRY4 and central nervous system cancer: In this study, we showed that SPRY4‐IT1 could suppress miR‐101‐3p levels in glioma cells, and EZH2 protein expression was restored in glioma cells after co‐transfection with siSPRY4‐IT1 and miR‐101‐3p inhibitor.